NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) (NITROFURANTOIN; NITROFURANTOIN, MACROCRY) — FDA Approval ANDA217357 (MANKIND PHARMA)
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) (NITROFURANTOIN; NITROFURANTOIN, MACROCRY) — FDA Approval ANDA217357 (MANKIND PHARMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS); Active ingredients: NITROFURANTOIN; NITROFURANTOIN, MACROCRY
| Brand name | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) |
|---|---|
| Active ingredients | NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE |
| Application number | ANDA217357 |
| Sponsor | MANKIND PHARMA |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20230711 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →